Congress funds brain aneurysm research to close a deadly gap
H.R. 2678 — Ellie’s Law · Filed by Brian Fitzpatrick (R-PA) · 55 cosponsors · Introduced Apr 7, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill authorizes $20 million per year for five years (2026–2030) to the National Institute of Neurological Disorders and Stroke to conduct research on unruptured brain aneurysms, with a focus on diverse patient populations. The bill is named after five people who died from ruptured aneurysms and includes detailed biographical narratives of each victim to establish the public-health case for the research investment.
Why we flagged it
The bill's sole operative mechanism is a straightforward appropriations authorization for federally directed medical research at a named NIH institute. The biographical framing is memorial in character but does not alter the bill's functional nature as a research-funding statute.
What the text implies
- The bill's emphasis on disparate impact (higher rupture rates in African Americans and Hispanics) may drive research design toward underrepresented populations, potentially improving health equity in aneurysm outcomes.
- The $20M annual authorization is modest relative to the $2B annual direct cost burden cited in findings; actual appropriations will depend on separate budget action and may fall short of research needs.
The full analysis lists 3 implications of this text.
Who stands to gain
National Institute of Neurological Disorders and Stroke (federal research institute); Academic medical centers and research universities conducting NIH-funded studies; Medical device and pharmaceutical companies developing aneurysm diagnostics and treatments